|
Recent Newsletters
High costs may limit impact of weight loss drug semaglutide | Postoperative delirium after TAVR |
August's Top 10 Stories: Multiple recalls | AI-enabled echo | New TAVR valves save time | 'Unfair' policies |
AI-enabled echo | Semaglutide & heart failure | Medicare price negotiations | ViV TMVR | More from the last week |
FDA shares update on troubled heart devices | Redo TAVR with balloon-expandable valves is safe & effective |
Looking back at ESC Congress 2023 | Pre-TAVR CT scans | Weight loss products recalled due to heart risks |
Statin use after bleeding strokes | Treating TAVR patients with low-flow, low-gradient AS & severe MR |
Cardiac Imaging Highlights: AI-enabled echo | Deferred testing for chest pain | Diagnosing HCM |